Perhaps one of the most important benefits of modern technology includes the advances that we have made in the field of medicine. For instance, many debilitating diseases are now being treated with the help of monoclonal antibodies. These antibodies are made to specifically target cell defects which cause everything from cancer to some types of arthritis. Your body produces natural antibodies in the immune system to ward off bacteria, viruses and other foreign invaders and these lab-created monoclonal antibodies work my mimicking these natural antibodies. Laboratory mice are often the source from which these antibodies derive, but sometimes the antibodies are cloned from human cells.
Monoclonal antibodies have a variety of different uses. For instance, monoclonal antibodies are used in several diagnostic tests to find traces of small amounts of drugs and toxins. Some pregnancy tests have been created with the help of monoclonal antibodies and also the diagnosis of AIDS also is made possible with their help. Monoclonal antibodies have also paved the way to modern advancements in medical technology by treating viral diseases that were once considered to be untreatable before.
Monoclonal antibody treatments have been used to help lessen the symptoms and severity of many diseases and this type of treatment is becoming more and more popular today. This type of treatment works by specifically binding the manufactured antibodies to target cells or proteins. In return, they will stimulate the patient's immune system to attack those cells. This makes treatment a bit more natural and there are fewer risks involved compared to other types of pharmaceutical drugs. It can also help prevent future diseases by destroying malignant tumor cells and stop tumor growth.
Monoclonal antibodies are used to help with cancer treatments such as radioimmunotherapy and radioimmunodetection. Cell membranes of cancerous cells are targeted with their help which is considered to be a much safer treatment since it avoids damaging or affecting other vital organs. Ritoxin is one specific cancer medication that has been created based on monoclonal antibodies that interferes with the growth and spread of cancer cells.. In addition, a new form of cancer treatment known as antibody-directed enzyme prodrug therapy (ADEPT) is a new form of cancer treatment that uses monoclonal antibodies. ADEPT treatments are still in experimental stages, but hopefully the outcome will be positive.
Today monoclonal antibody treatments are used for other types of diseases aside from cancer. Further advancement and research have helped develop monoclonal antibodies which are now used for many autoimmune diseases, including rheumatoid arthritis, macular degeneration, Crohn's disease, psoriasis and much more. The drugs used to treat autoimmune diseases that were created using monoclonal antibodies can be easily identified as the drug names all end in -mab, which stands for monoclonal antibody.
There is still much to do since scientists are still continuing their research and study about these manufactured antibodies. There is still room for improvement since monoclonal antibody treatment is mainly in developmental stages. We hope to see and hear more of this drug and its advancements in fighting many diseases, especially those such as Alzheimer's, Lou Gehrig's disease and Huntington's disease, which are fatal and have no cure as of yet.
Monoclonal antibodies have a variety of different uses. For instance, monoclonal antibodies are used in several diagnostic tests to find traces of small amounts of drugs and toxins. Some pregnancy tests have been created with the help of monoclonal antibodies and also the diagnosis of AIDS also is made possible with their help. Monoclonal antibodies have also paved the way to modern advancements in medical technology by treating viral diseases that were once considered to be untreatable before.
Monoclonal antibody treatments have been used to help lessen the symptoms and severity of many diseases and this type of treatment is becoming more and more popular today. This type of treatment works by specifically binding the manufactured antibodies to target cells or proteins. In return, they will stimulate the patient's immune system to attack those cells. This makes treatment a bit more natural and there are fewer risks involved compared to other types of pharmaceutical drugs. It can also help prevent future diseases by destroying malignant tumor cells and stop tumor growth.
Monoclonal antibodies are used to help with cancer treatments such as radioimmunotherapy and radioimmunodetection. Cell membranes of cancerous cells are targeted with their help which is considered to be a much safer treatment since it avoids damaging or affecting other vital organs. Ritoxin is one specific cancer medication that has been created based on monoclonal antibodies that interferes with the growth and spread of cancer cells.. In addition, a new form of cancer treatment known as antibody-directed enzyme prodrug therapy (ADEPT) is a new form of cancer treatment that uses monoclonal antibodies. ADEPT treatments are still in experimental stages, but hopefully the outcome will be positive.
Today monoclonal antibody treatments are used for other types of diseases aside from cancer. Further advancement and research have helped develop monoclonal antibodies which are now used for many autoimmune diseases, including rheumatoid arthritis, macular degeneration, Crohn's disease, psoriasis and much more. The drugs used to treat autoimmune diseases that were created using monoclonal antibodies can be easily identified as the drug names all end in -mab, which stands for monoclonal antibody.
There is still much to do since scientists are still continuing their research and study about these manufactured antibodies. There is still room for improvement since monoclonal antibody treatment is mainly in developmental stages. We hope to see and hear more of this drug and its advancements in fighting many diseases, especially those such as Alzheimer's, Lou Gehrig's disease and Huntington's disease, which are fatal and have no cure as of yet.
About the Author:
Armand Zeiders loves writing about biomedical research. To get more information about custom monoclonal antibody service and other biotech services, please visit the PrimmBiotech.com site now.
No comments:
Post a Comment